BridgeBio International GmbH
Developing transformative medicines for rare genetic conditions quickly.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2025
- Grundat
Nyckelbeslutsfattare
Andrea Ellis
Director
Neil Kumar, Ph.D.
Chief Executive Officer, Director
Frank McCormick, Ph.D.
Director, Chairman of Oncology
Ronald J. Daniels
Director
+10 fler kontakter i Funnelfeedr
Beskrivning
BridgeBio Pharma is a company dedicated to developing transformative medicines for patients suffering from rare genetic conditions. They aim to bridge the gap between scientific advancements and meaningful treatments for underserved populations. The organization operates using a unique, decentralize...